Formula #1 Review

by Herbals-Unlimited
Formula #1
7.25 out of 10 based on 0 user ratings
Formula #1
Formula #1
Written by: Brain Research Supplements
Date Published: 2012-06-23
7.25 / 10 stars
Formula #1  Review

Is Formula #1 Right For You?

Formula #1 is a dietary supplement (available in capsule or liquid form) designed to promote cardiovascular health.

This supplement is manufactured by a relatively new company, located in the USA named Herbals-Unlimited. They offer a wide variety of products at reasonable prices, but they are not very popular. To attract customers, first-time buyers and members are offered substantial discounts. More information about the company background is posted on their website.

The manufacturer claims supplementation with this product can prevent cardiovascular problems and heavy metal poisoning to some extent. As it contains EDTA, Formula #1 may avoid the collection of platelets on the lining of the vessel (such as arteries) which can otherwise lead to the formation of blood clots, which itself is associated with atheromatous plaque formation or rupture, and thereby ultimately disrupts blood flow. The makers provide little information about this product but still they claim it is one of the best cardiovascular supplements on the market.

Ingredients of Formula #1

Formula One (liquid form) includes the following ingredients: Vitamin C, Vitamin B12, Honey, royal jelly, Vitamin B6, biotin, acetylcholine, honeybee pollen, Disodium EDTA, magnesium chloride fortified with vitamin B12.

Formula #1 (gelcaps) includes the following ingredients: Vitamin B12, Royal Jelly, Sodium Alginate, Alpha-lipoic Acid, Rose Hips, Bee Pollen, gelatin, glycerin, yellow beeswax, lecithin, caramel powder, silica, disodium EDTA.

Rate this post
shareShare on FacebookShare on Google+Pin on Pinterest
Have a comment or question about Formula #1 Review?

(Please Note: Comments or questions which include website links or do not contain positive factual language will not be posted.)

Your email address will not be published.